Northside Hospital, Inc.-GCS/Macon

Macon, Georgia 31217

0 studies enrolling now · 4 studies all time

What they study most

Breast Neoplasms, Genes, BRCA 1, HER2 Positive Breast Cancer, HER2-positive Breast Cancer, Locally Advanced or Metastatic Solid Tumors

Studies at this site

• A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer — Running, not enrolling
• A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer — Completed
• PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid Tumors — Stopped early
• Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors — Stopped early